Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Stadtmauer

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cellsJ N Winter, H M Lazarus, A Rademaker, et al.
Leukemia|January 18, 2008
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 studyJ F San-Miguel, P G Richardson, P Sonneveld, et al.
Medical Oncology (Northwood, London, England)|January 5, 2000
Stem cell transplantation for metastatic breast cancer: analysis of tumor contaminationE A Stadtmauer, D E Tsai, C J Sickles, et al.
Bone Marrow Transplantation|October 6, 2005
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphomaC Andreadis, S J Schuster, E A Chong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North AmericaK H Antman, P A Rowlings, W P Vaughan, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Leukemia|June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)S Giralt, E A Stadtmauer, J L Harousseau, et al.
Bone Marrow Transplantation|February 20, 2013
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experienceG A Hale, M Arora, K W Ahn, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cellsJ N Winter, H M Lazarus, A Rademaker, et al.
Leukemia|January 18, 2008
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 studyJ F San-Miguel, P G Richardson, P Sonneveld, et al.
Medical Oncology (Northwood, London, England)|January 5, 2000
Stem cell transplantation for metastatic breast cancer: analysis of tumor contaminationE A Stadtmauer, D E Tsai, C J Sickles, et al.
Bone Marrow Transplantation|October 6, 2005
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphomaC Andreadis, S J Schuster, E A Chong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North AmericaK H Antman, P A Rowlings, W P Vaughan, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Leukemia|June 26, 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)S Giralt, E A Stadtmauer, J L Harousseau, et al.
Bone Marrow Transplantation|February 20, 2013
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experienceG A Hale, M Arora, K W Ahn, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 6